Email ID
Password
Sign me in automatically next time
clinica
RECENT TWEETS    
25 May 2015

 
22 May 2015
Changes to New Zealand’s medtech procurement process are underway, with the Pharmaceutical Management Agency taking over management of hospital medical devices. Faye Sumner of the Medical Technology Association of New Zealand discusses the market ...
21 May 2015
Transcatheter aortic valve implantation (TAVI) may have been around for a while, but it was still a big topic at this year’s EuroPCR, held in Paris, France, on 19-22 May. And the topic on everyone’s lips on Thursday was the potential side-effect of ...
21 May 2015
Edwards Lifesciences’ presence at this year’s EuroPCR in Paris, France was overshadowed somewhat by its announcement earlier in the meeting that it has voluntarily paused the clinical program for its Fortis transcatheter mitral valve following ...
20 May 2015
Edwards Lifesciences has hit a snag with its transcatheter mitral valve program after it was forced to pause a clinical trial of its investigational Fortis valve. The firm has seen “evidence of valve thrombosis that we believe warrants additional ...
 
22 May 2015
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded ...
22 May 2015
Stent wars are back – and this time they’re bioresorbable. The leader in the fully-resorbable stent sector, Abbott, announced the CE mark of its new Absorb GT1 at the EuroPCR meeting, held in Paris, France on 19-22 May. The new product combines the ...
21 May 2015
Changes to two important EU medical device guidelines – on competent authority assessment of a medical device clinical investigation, and on reporting serious adverse events associated with devices during a clinical investigation – will be presented ...
21 May 2015
Transcatheter aortic valve implantation (TAVI) may have been around for a while, but it was still a big topic at this year’s EuroPCR, held in Paris, France, on 19-22 May. And the topic on everyone’s lips on Thursday was the potential side-effect of ...
 
15 May 2015
Around 71% of Africa’s health burden comes from communicable diseases but non-communicable diseases such as cancer are increasing rapidly. This shift brings growth opportunities for companies such as radiotherapy specialist Varian Medical Systems. ...
15 May 2015
UK pharma firm Circassia Pharmaceuticals has agreed to buy Swedish asthma diagnostic specialist Aerocrine for SEK1.78bn ($219m). The offer of SEK2.55 per share is an 85% premium over Aerocrine’s share price on 22 April, when speculation of the ...
14 May 2015
The overwhelming majority of currently approved companion diagnostics are for oncology indications, but AstraZeneca wants to change all that and has signed to deals aimed at bringing companion diagnostics to respiratory disorders and heart disease. ...
13 May 2015
Danaher has definitively agreed to buy filtration technology specialist Pall in a bid to strengthen its position in the broader life sciences space. Danaher will pay $127.20 per share in cash, giving Pall a total enterprise value of approximately ...
 
22 May 2015
Changes to New Zealand’s medtech procurement process are underway, with the Pharmaceutical Management Agency taking over management of hospital medical devices. Faye Sumner of the Medical Technology Association of New Zealand discusses the market ...
20 May 2015
Details now emerging from the 36 th meeting of the Competent Authorities for Medical Devices (CAMD) group held in February show that market surveillance and clinical evaluation have been established as key work areas for the group. The primary area ...
19 May 2015
Efforts are under way to revise a key international medtech standard, ISO 14155: 2011 on clinical investigation of medical devices. The review process involves "several working [group] meetings and international reviews which will take time", ...
19 May 2015
The final submission deadline for medical device companies wishing to keep their products on the Malaysian market as the country transitions to a conformity assessment-based system is approaching fast. June 30 2015 is the last date by which ...
 
Sorin, Cyberonics reveal post-merger exec team With the merger of heart device company Sorin and neurostimulation specialist Cyberonics on track to close at the end of the third quarter, the ...
New CEO brings commercial nous to NetScientific NetScientific, the UK group which invests in biomedical and healthcare companies, has appointed François Martelet as CEO and board director. Dr ...
Siemens exec to lead Curetis commercialization Molecular diagnostics firm Curetis has appointed Achim Plum to the newly-created role of chief commercial officer. Dr Plum’s in vitro diagnostics ...
20 May 2015
Ashley Yeo

How the promised EU in/out referendum for the UK, in 2016 or 2017, will affect industry is now the big concern for UK medtech companies, as the dust settles on the UK general election. There is no certainty as to the outcome, and the slim 12-seat ...

13 May 2015
Ashley Yeo

While the attention of the EU industry has been fixed on how the EU Council will play the controversial elements of the proposed EU Medical Device Regulation (MDR) – the Article 44 scrutiny clause above all else – tougher market access rules for ...

 
20 May 2015
How the promised EU in/out referendum for the UK, in 2016 or 2017, will affect industry is now the big concern for UK medtech companies, as the dust settles on the UK general election. There is no certainty as to the outcome, and the slim 12-seat ...
 EuroPCR: TAVI goliaths battle it out; Direct Flow impresses ...   EuroPCR: TAVI leaflet thickening side-effect should not chan...
13 May 2015
While the attention of the EU industry has been fixed on how the EU Council will play the controversial elements of the proposed EU Medical Device Regulation (MDR) – the Article 44 scrutiny clause above all else – tougher market access rules for ...
01 May 2015
With the wearable medical device market estimated to reach $5.8bn by 2019 and the global mobile health market predicted to be worth around $26bn by 2017, healthcare systems around the world are gearing up for potentially widespread implementation of ...
22 October 2014
Amanda Maxwell

The future regulation of high-risk devices is one of the trickiest subjects in the proposed EU Medical Device Regulation (MDR) on which to reach final agreement, with the different parties involved seemingly at loggerheads. Delegates at the European ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

30 April 2015
Madeleine Armstrong

Sphere Medical has been on Clinica’s radar for some time, but the UK firm has lately been ramping up its activities, appointing a new CEO and getting CE mark approval for its Proxima 3 blood analyzer last year. The company has just closed a share ...

 
20 April 2015

Specialty area(s): Devices for bowel control Based in: Sunnyvale, California Founded in: 2010 No. of employees: 18 Total investment received to date: Undisclosed Investors: Led by Norwich Ventures

 
 
 
© 2015 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36